Structure-based Design of Prefusion-stabilized SARS-CoV-2 Spikes

Mostrar otras versiones (1)

The COVID-19 pandemic caused by the novel coronavirus SARS-CoV-2 has led to accelerated efforts to develop therapeutics, diagnostics, and vaccines to mitigate this public health emergency. A key target of these efforts is the spike (S) protein, a large trimeric class I fusion protein that is metasta...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsieh, Ching-Lin, Goldsmith, Jory A., Schaub, Jeffrey M., DiVenere, Andrea M., Kuo, Hung-Che, Javanmardi, Kamyab, Le, Kevin C., Wrapp, Daniel, Lee, Alison Gene-Wei, Liu, Yutong, Chou, Chia-Wei, Byrne, Patrick O., Hjorth, Christy K., Johnson, Nicole V., Ludes-Meyers, John, Nguyen, Annalee W., Park, Juyeon, Wang, Nianshuang, Amengor, Dzifa, Maynard, Jennifer A., Finkelstein, Ilya J., McLellan, Jason S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7302215/
https://www.ncbi.nlm.nih.gov/pubmed/32577660
http://dx.doi.org/10.1101/2020.05.30.125484

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7302215/
https://www.ncbi.nlm.nih.gov/pubmed/32577660
http://dx.doi.org/10.1101/2020.05.30.125484

Ejemplares similares